Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-30

Clinical Trial Results: A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating Baxdrostat for uncontrolled hypertension on multiple medications, including resistant hypertension; results posted after comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baxdrostat (Baxdrostat)

Snippet

Sponsor: AstraZeneca | Conditions: Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2026-07-30